{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:51:12Z","timestamp":1792255872940,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570755"],"award-info":[{"award-number":["82570755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Beijing","award":["7252067"],"award-info":[{"award-number":["7252067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56705-0","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:09:55Z","timestamp":1781795395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reticulocalbin 3 as a novel biomarker for assessing liver disease severity and identifying decompensated status in cirrhosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Feng-Wei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"2","key":"56705_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 69 (2), 406\u2013460. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024 (2018).","journal-title":"J. Hepatol."},{"issue":"10308","key":"56705_CR2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s, P. et al. Liver cirrhosis. Lancet 398 (10308), 1359\u20131376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X (2021).","journal-title":"Lancet"},{"issue":"Suppl 1","key":"56705_CR3","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.jhep.2021.01.018","volume":"75","author":"R Jalan","year":"2021","unstructured":"Jalan, R. et al. New clinical and pathophysiological perspectives defining the trajectory of cirrhosis. J. Hepatol. 75 (Suppl 1), S14\u201326. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.018 (2021).","journal-title":"J. Hepatol."},{"key":"56705_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis, R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J. Hepatol. 63, 743\u2013752 (2015).","journal-title":"J. Hepatol."},{"issue":"7","key":"56705_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","volume":"56","author":"H Yoshiji","year":"2021","unstructured":"Yoshiji, H. et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. J. Gastroenterol. 56 (7), 593\u2013619. https:\/\/doi.org\/10.1007\/s00535-021-01788-x (2021).","journal-title":"J. Gastroenterol."},{"issue":"4","key":"56705_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3760\/cma.j.cn311367-20230228-00093","volume":"43","author":"\u4e2d\u534e\u533b\u5b66\u4f1a\u6d88\u5316\u75c5\u5b66\u5206\u4f1a.\u4e2d\u56fd\u809d\u786c\u5316\u4e34\u5e8a\u8bca\u6cbb\u5171\u8bc6\u610f\u89c1","year":"2023","unstructured":"\u4e2d\u534e\u533b\u5b66\u4f1a\u6d88\u5316\u75c5\u5b66\u5206\u4f1a.\u4e2d\u56fd\u809d\u786c\u5316\u4e34\u5e8a\u8bca\u6cbb\u5171\u8bc6\u610f\u89c1. Zhonghua Xiaohua Zazhi ;43 (4):227\u2013247. doi:https:\/\/doi.org\/10.3760\/cma.j.cn311367-20230228-00093 (2023).","journal-title":"Zhonghua Xiaohua Zazhi"},{"key":"56705_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1365-2036.2005.02691.x","volume":"22","author":"E Cholongitas","year":"2005","unstructured":"Cholongitas, E. et al. Systematic review: the model for end-stage liver disease\u2013should it replace Child-Pugh\u2019s classification for assessing prognosis in cirrhosis? Aliment. Pharmacol. Ther. 22, 1079\u20131089 (2005).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"56705_CR8","doi-asserted-by":"publisher","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","volume":"95","author":"Y Peng","year":"2016","unstructured":"Peng, Y., Qi, X. & Guo, X. Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Med. (Baltim). 95, e2877 (2016).","journal-title":"Med. (Baltim)."},{"key":"56705_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico, G., Garcia-Tsao, G. & Pagliaro, L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol. 44, 217\u2013231 (2006).","journal-title":"J. Hepatol."},{"issue":"22","key":"56705_CR10","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","volume":"382","author":"V Arroyo","year":"2020","unstructured":"Arroyo, V., Moreau, R. & Jalan, R. Acute-on-Chronic Liver Failure. N Engl. J. Med. 382 (22), 2137\u20132145. https:\/\/doi.org\/10.1056\/NEJMra1914900 (2020).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"56705_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14309\/ajg.0000000000003056","volume":"120","author":"VT Kronsten","year":"2025","unstructured":"Kronsten, V. T. & Shawcross, D. L. Clinical Implications of Inflammation in Patients With Cirrhosis. Am. J. Gastroenterol. 120 (1), 65\u201374. https:\/\/doi.org\/10.14309\/ajg.0000000000003056 (2025).","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"56705_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V Arroyo","year":"2021","unstructured":"Arroyo, V. et al. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J. Hepatol. 74 (3), 670\u2013685. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.048 (2021).","journal-title":"J. Hepatol."},{"key":"56705_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mam.2017.11.007","volume":"62","author":"N Papadopoulos","year":"2018","unstructured":"Papadopoulos, N. & Lennartsson, J. The PDGF\/PDGFR pathway as a drug target. Mol. Aspects Med. 62, 75\u201388. https:\/\/doi.org\/10.1016\/j.mam.2017.11.007 (2018).","journal-title":"Mol. Aspects Med."},{"issue":"120","key":"56705_CR14","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.5754\/hge12388","volume":"59","author":"XC Diang","year":"2012","unstructured":"Diang, X. C. et al. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients. Hepatogastroenterology 59 (120), 2357\u20132360. https:\/\/doi.org\/10.5754\/hge12388 (2012).","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"56705_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.26444\/aaem\/115997","volume":"27","author":"E Kurys-Denis","year":"2020","unstructured":"Kurys-Denis, E. et al. PDGF-BB homodimer serum level\u2014a good indicator of the severity of alcoholic liver cirrhosis. Ann. Agric. Environ. Med. 27 (1), 80\u201385. https:\/\/doi.org\/10.26444\/aaem\/115997 (2020).","journal-title":"Ann. Agric. Environ. Med."},{"issue":"11","key":"56705_CR16","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3748\/wjg.v9.i11.2490","volume":"9","author":"BB Zhang","year":"2003","unstructured":"Zhang, B. B. et al. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis. World J. Gastroenterol. 9 (11), 2490\u20132496. https:\/\/doi.org\/10.3748\/wjg.v9.i11.2490 (2003).","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"56705_CR17","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/ijc.28927","volume":"136","author":"M Schlesinger","year":"2015","unstructured":"Schlesinger, M. & Bendas, G. Vascular cell adhesion molecule-1 (VCAM-1)\u2014an increasing insight into its role in tumorigenicity and metastasis. Int. J. Cancer. 136 (11), 2504\u20132514. https:\/\/doi.org\/10.1002\/ijc.28927 (2015).","journal-title":"Int. J. Cancer"},{"issue":"6","key":"56705_CR18","doi-asserted-by":"publisher","first-page":"e143690","DOI":"10.1172\/JCI143690","volume":"131","author":"K Furuta","year":"2021","unstructured":"Furuta, K. et al. Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis. J. Clin. Invest. 131 (6), e143690. https:\/\/doi.org\/10.1172\/JCI143690 (2021).","journal-title":"J. Clin. Invest."},{"key":"56705_CR19","doi-asserted-by":"publisher","first-page":"983255","DOI":"10.3389\/fimmu.2022.983255","volume":"13","author":"Q Guo","year":"2022","unstructured":"Guo, Q. et al. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis. Front. Immunol. 13, 983255. https:\/\/doi.org\/10.3389\/fimmu.2022.983255 (2022).","journal-title":"Front. Immunol."},{"issue":"8","key":"56705_CR20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ijo.2017.102","volume":"41","author":"S Lefere","year":"2017","unstructured":"Lefere, S. et al. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. Int. J. Obes. (Lond). 41 (8), 1207\u20131213. https:\/\/doi.org\/10.1038\/ijo.2017.102 (2017).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"1","key":"56705_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0014-5793(99)01780-9","volume":"466","author":"B Honor\u00e9","year":"2000","unstructured":"Honor\u00e9, B. & Vorum, H. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett. 466 (1), 11\u201318. https:\/\/doi.org\/10.1016\/s0014-5793(99)01780-9 (2000).","journal-title":"FEBS Lett."},{"issue":"1","key":"56705_CR22","doi-asserted-by":"publisher","first-page":"12192","DOI":"10.1038\/s41598-017-12305-7","volume":"7","author":"E Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts. Sci. Rep. 7 (1), 12192. https:\/\/doi.org\/10.1038\/s41598-017-12305-7 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"56705_CR23","doi-asserted-by":"publisher","first-page":"10868","DOI":"10.1038\/s41598-021-90258-8","volume":"11","author":"NR Park","year":"2021","unstructured":"Park, N. R. et al. Reticulocalbin 3 is involved in postnatal tendon development by regulating collagen fibrillogenesis and cellular maturation. Sci. Rep. 11 (1), 10868. https:\/\/doi.org\/10.1038\/s41598-021-90258-8 (2021).","journal-title":"Sci. Rep."},{"issue":"3","key":"56705_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1165\/rcmb.2017-0347OC","volume":"59","author":"J Jin","year":"2018","unstructured":"Jin, J. et al. Reticulocalbin 3 Deficiency in Alveolar Epithelium Exacerbated Bleomycin-induced Pulmonary Fibrosis. Am. J. Respir Cell. Mol. Biol. 59 (3), 320\u2013333. https:\/\/doi.org\/10.1165\/rcmb.2017-0347OC (2018).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"issue":"1","key":"56705_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00408-025-00807-5","volume":"203","author":"F Ding","year":"2025","unstructured":"Ding, F. et al. Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients. Lung 203 (1), 50. https:\/\/doi.org\/10.1007\/s00408-025-00807-5 (2025).","journal-title":"Lung"},{"key":"56705_CR26","doi-asserted-by":"publisher","first-page":"1179342","DOI":"10.3389\/fneph.2023.1179342","volume":"3","author":"J Duan","year":"2023","unstructured":"Duan, J. et al. Predicting SARS-CoV-2 infection among hemodialysis patients using multimodal data. Front. Nephrol. 3, 1179342. https:\/\/doi.org\/10.3389\/fneph.2023.1179342 (2023).","journal-title":"Front. Nephrol."},{"issue":"1","key":"56705_CR27","doi-asserted-by":"publisher","first-page":"23588","DOI":"10.1038\/s41598-024-74967-4","volume":"14","author":"L Xiao","year":"2024","unstructured":"Xiao, L. et al. Predicting SARS-CoV-2 infection among hemodialysis patients using deep neural network methods. Sci. Rep. 14 (1), 23588. https:\/\/doi.org\/10.1038\/s41598-024-74967-4 (2024).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56705-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:42:21Z","timestamp":1788820941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56705-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56705"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56705-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Hospital Ethics Committee (No. LL-2022-141-K) and was registered at ClinicalTrials.gov (NCT05932927).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27988"}}